NervGen Pharma Corp NGENF

NervGen Article is out today, link below

[Geodan2]

Article published https://ceo.ca/@geodan/nervgen-regenerates-neurons-what-is-a-drug-that-reverses-paralysis-ms-stroke-and-alzheimers-worth

NervGen Regenerates Neurons, What Is A Drug That Reverses Paralysis, MS, Stroke And Alzheimer's Worth?

Summary
NervGen has already regenerated neurons under the microscope and in live rats with severed spinal cords. The rats regained most of the function in paralyzed legs.

The market cap of NervGen is under $80 million. It is currently in Phase 1 FDA trials in humans and is about to go into Phase 2.

NervGen has exclusive rights to the technology from Case Western University. It is backed by top experts in the field and staffed by very high-level pharma executives.

It has no competitors that can repair damage to the nervous system. If it works 50% as well in humans as in animals, a $15 billion market cap is feasible.

I have it on CEO now, it is non exclusive, will put on Seeking Alpha later.

Please spread it around. Thanks!

[Geodan2]

No one is here.  Best stock have ever found and it is that way because people do not know about it. https://ceo.ca/  article is on front page of CEO now. One reason NervGen has not taken off more is that it has greatly outperformed the sector, but the sector is way down in hyper crash. The BBC drug trials ETF is down 52% in last year while NGENF is up 33%, a 85% outperform